| Clinical evaluation of 49 patients with hypoparathyroidism | Murat SERT, Sinan KIRIM, Tamer TETİKER | 50–52 |
| Endocrine status in cirrhosis | Gürcan KISAKOL | 53–57 |
| Body composition referance values of adult men and women according to their body mass index grouped as normal weight, overweight, obese and morbid obese | Aliye Özenoğlu, Hüsrev HATEMİ, Ertuğrul TAŞAN, G. CAN | 58–63 |
| Relation between bone markers and bone density in men | Candeğer YILMAZ, Gürcan KISAKOL | 64–68 |
| Activities of protein-C, protein-S and antithrombin-III in type 2 diabetes mellitus | Ersin AKARSU, İlyas ÇAPOĞLU, Mehmet GÜNDOĞDU, Necdet ÜNÜVAR, Güngör AKÇAY, Hasan KAYA | 69–71 |
| Plasma PAI-1 levels in type 2 diabetic patients | Nezaket EREN, Fatma TURGAY, Erdinç ŞİRİN, Sevgi SOYÖZ, Şebnem CİĞERLİ | 75–78 |
| Comparison of combined bone/Ga-67 and bone/Tc-99m HMPAO labeled leukocyte scintigraphies in diabetic foot ulcers | Tanju Yusuf ERDİL, İlhami USLU, Hüsrev HATEMİ, Kutlan ÖZKER, Mustafa ÖZYAZAR, Çetin ÖNSEL, Nafiz BAĞRIAÇIK, Halil Turgut TUROĞLU | 79–82 |
| A case report of a patient whom 17$beta$ hydroxysteroid dehydrogenase-3 deficiency is thought to cause the clinical and biochemical findings of the disorder of sexuel differentiation | M. Sait GÖNEN, Sibel MİL, Ş. Nur SAĞMANLIGİL, İbrahim GÜNEY | 83–84 |
| Administration of combined (GH and LH-RH) therapy for the patients who are in puberty and GH deficient | Oğuz Alev KUTLU, H. Tahsin TEZİÇ, Nihal MEMİOĞLU, M. Şeniz YÜKSEL | 85–88 |
| A case of hyperthyroidism in a patient with Down's syndrome | Ramis ÇOLAK, Mustafa ÇALIK, Fahri BAYRAM, Kürşad ÜNLÜHIZARCI, Selim KURTOĞLU, Fahrettin KELEŞTİMUR | 89–90 |